Elequin Capital’s Nomura Holdings NMR Stock Holding History

Elequin Capital’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Buy	1,181 +316	+37%	+$2.63K	﹤0.01%	451
2026 Q1	$6.83K	Buy	+865	New	+$7.45K	﹤0.01%	364

Other funds holding NMR

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Elequin Capital's NMR Position: Q2 2026 in Review

Elequin Capital increased its Nomura Holdings (NMR) stake by 37% in Q2 2026, buying an estimated $2.63K and bringing the position to 1,181 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Elequin Capital first reported a position in NMR in Q1 2026 and has held it in 2 quarters since. 301 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

Elequin Capital held 1,181 shares of Nomura Holdings worth $10.4K as of Q2 2026.
Elequin Capital bought 316 Nomura Holdings shares in Q2 2026, an estimated $2.63K.
Nomura Holdings made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #451 holding.
Elequin Capital first reported a position in Nomura Holdings in Q1 2026 and has held it in 2 quarters since.
301 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.